IT201700104446A1 - Compositions, uses and methods for treatment of infertility and subfertility - Google Patents
Compositions, uses and methods for treatment of infertility and subfertilityInfo
- Publication number
- IT201700104446A1 IT201700104446A1 IT102017000104446A IT201700104446A IT201700104446A1 IT 201700104446 A1 IT201700104446 A1 IT 201700104446A1 IT 102017000104446 A IT102017000104446 A IT 102017000104446A IT 201700104446 A IT201700104446 A IT 201700104446A IT 201700104446 A1 IT201700104446 A1 IT 201700104446A1
- Authority
- IT
- Italy
- Prior art keywords
- subfertility
- infertility
- compositions
- treatment
- methods
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/38—Albumins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Reproductive Health (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Priority Applications (17)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT102017000104446A IT201700104446A1 (it) | 2017-09-19 | 2017-09-19 | Compositions, uses and methods for treatment of infertility and subfertility |
EP18773976.8A EP3684372A1 (en) | 2017-09-19 | 2018-09-18 | Compositions, uses and methods for treatment of infertility and subfertility |
EA202090790A EA202090790A1 (ru) | 2017-09-19 | 2018-09-18 | Композиции, применение и способы лечения бесплодия и недостаточности репродуктивной функции |
PCT/EP2018/075203 WO2019057709A1 (en) | 2017-09-19 | 2018-09-18 | COMPOSITIONS, USES AND METHODS FOR THE TREATMENT OF INFERTILITY AND SUB-FERTILITY |
JOP/2020/0065A JOP20200065A1 (ar) | 2017-09-19 | 2018-09-18 | تركيبات واستخدامات وطرق لعلاج العُقم وضعف الخصوبة |
US16/647,715 US11364282B2 (en) | 2017-09-19 | 2018-09-18 | Compositions, uses and methods for treatment of infertility and subfertility |
MX2020002914A MX2020002914A (es) | 2017-09-19 | 2018-09-18 | Composiciones, usos y procedimientos para el tratamiento de la infertilidad y la subfertilidad. |
MA050163A MA50163A (fr) | 2017-09-19 | 2018-09-18 | Compositions, utilisations et méthodes pour le traitement de l'infertilité et de la sous-fertilité |
SG11202001756YA SG11202001756YA (en) | 2017-09-19 | 2018-09-18 | Compositions, uses and methods for treatment of infertility and subfertility |
BR112020005537-9A BR112020005537A2 (pt) | 2017-09-19 | 2018-09-18 | composição, combinação de inositol e alfa-lactalbumina para uso, uso do inositol, kit e produto alimentício ou bebida |
CA3075582A CA3075582A1 (en) | 2017-09-19 | 2018-09-18 | Compositions, uses and methods for treatment of infertility and subfertility |
KR1020207011202A KR102468673B1 (ko) | 2017-09-19 | 2018-09-18 | 불임 및 난임 치료를 위한 조성물, 용도 및 방법 |
ARP180102651 AR112700A1 (es) | 2017-09-19 | 2018-09-18 | Composiciones, usos y métodos para el tratamiento de infertilidad y subfertilidad |
UY0001037885A UY37885A (es) | 2017-09-19 | 2018-09-18 | Composiciones, usos y métodos para el tratamiento de infertilidad y subfertilidad |
CONC2020/0002658A CO2020002658A2 (es) | 2017-09-19 | 2020-03-09 | Composiciones, usos y procedimientos para el tratamiento de la infertilidad y la subfertilidad |
CL2020000684A CL2020000684A1 (es) | 2017-09-19 | 2020-03-16 | Composiciones, usos y procedimientos para el tratamiento de la infertilidad y la subfertilidad. |
US17/528,959 US20220062388A1 (en) | 2017-09-19 | 2021-11-17 | Compositions, uses and methods for treatment of infertility and subfertility |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT102017000104446A IT201700104446A1 (it) | 2017-09-19 | 2017-09-19 | Compositions, uses and methods for treatment of infertility and subfertility |
Publications (1)
Publication Number | Publication Date |
---|---|
IT201700104446A1 true IT201700104446A1 (it) | 2019-03-19 |
Family
ID=60991464
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IT102017000104446A IT201700104446A1 (it) | 2017-09-19 | 2017-09-19 | Compositions, uses and methods for treatment of infertility and subfertility |
Country Status (16)
Country | Link |
---|---|
US (2) | US11364282B2 (it) |
EP (1) | EP3684372A1 (it) |
KR (1) | KR102468673B1 (it) |
AR (1) | AR112700A1 (it) |
BR (1) | BR112020005537A2 (it) |
CA (1) | CA3075582A1 (it) |
CL (1) | CL2020000684A1 (it) |
CO (1) | CO2020002658A2 (it) |
EA (1) | EA202090790A1 (it) |
IT (1) | IT201700104446A1 (it) |
JO (1) | JOP20200065A1 (it) |
MA (1) | MA50163A (it) |
MX (1) | MX2020002914A (it) |
SG (1) | SG11202001756YA (it) |
UY (1) | UY37885A (it) |
WO (1) | WO2019057709A1 (it) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008155651A2 (en) * | 2007-06-20 | 2008-12-24 | Lo.Li. Pharma S.R.L. | Inositol for induction of ovulation |
WO2013076121A1 (en) * | 2011-11-22 | 2013-05-30 | Lo.Li. Pharma S.R.L. | Pharmaceutical composition comprising myo-inositol and d-chiro-inositol |
US20140294795A1 (en) * | 2013-03-28 | 2014-10-02 | Houn Simon Hsia | Nutritional Composition |
CN104365997A (zh) * | 2014-12-14 | 2015-02-25 | 河南联合英伟饲料有限公司 | 一种家畜幼仔奶粉饲料 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20010006027A (ko) | 1997-04-03 | 2001-01-15 | 포인트 바이오메디칼 코퍼레이션 | 방광내 약물 송달 시스템 |
EP1228707A1 (en) | 2001-02-01 | 2002-08-07 | Campina Melkunie B.V. | Use of alpha-lactalbumin as prebiotic agent |
GB0205347D0 (en) * | 2002-03-07 | 2002-04-24 | Svanborg Catharina | Biologically active complex |
MX2012010488A (es) * | 2012-09-11 | 2014-03-26 | Nucitec Sa De Cv | Formula infantil para el optimo crecimiento, proteccion gastrointestinal y proteccion inmunologica de infantes. |
MX2017001804A (es) * | 2014-08-08 | 2017-04-27 | Nestec Sa | Mioinositol y uno o mas probioticos y sus usos. |
-
2017
- 2017-09-19 IT IT102017000104446A patent/IT201700104446A1/it unknown
-
2018
- 2018-09-18 MX MX2020002914A patent/MX2020002914A/es unknown
- 2018-09-18 WO PCT/EP2018/075203 patent/WO2019057709A1/en active Application Filing
- 2018-09-18 KR KR1020207011202A patent/KR102468673B1/ko active IP Right Grant
- 2018-09-18 JO JOP/2020/0065A patent/JOP20200065A1/ar unknown
- 2018-09-18 BR BR112020005537-9A patent/BR112020005537A2/pt unknown
- 2018-09-18 AR ARP180102651 patent/AR112700A1/es unknown
- 2018-09-18 EA EA202090790A patent/EA202090790A1/ru unknown
- 2018-09-18 MA MA050163A patent/MA50163A/fr unknown
- 2018-09-18 EP EP18773976.8A patent/EP3684372A1/en active Pending
- 2018-09-18 US US16/647,715 patent/US11364282B2/en active Active
- 2018-09-18 SG SG11202001756YA patent/SG11202001756YA/en unknown
- 2018-09-18 UY UY0001037885A patent/UY37885A/es unknown
- 2018-09-18 CA CA3075582A patent/CA3075582A1/en active Pending
-
2020
- 2020-03-09 CO CONC2020/0002658A patent/CO2020002658A2/es unknown
- 2020-03-16 CL CL2020000684A patent/CL2020000684A1/es unknown
-
2021
- 2021-11-17 US US17/528,959 patent/US20220062388A1/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008155651A2 (en) * | 2007-06-20 | 2008-12-24 | Lo.Li. Pharma S.R.L. | Inositol for induction of ovulation |
WO2013076121A1 (en) * | 2011-11-22 | 2013-05-30 | Lo.Li. Pharma S.R.L. | Pharmaceutical composition comprising myo-inositol and d-chiro-inositol |
US20140294795A1 (en) * | 2013-03-28 | 2014-10-02 | Houn Simon Hsia | Nutritional Composition |
CN104365997A (zh) * | 2014-12-14 | 2015-02-25 | 河南联合英伟饲料有限公司 | 一种家畜幼仔奶粉饲料 |
Non-Patent Citations (1)
Title |
---|
COSTANTINO D ET AL: "Metabolic and hormonal effects of myo-inositol in women with polycystic ovary syndrome: A double-blind trial", vol. 13, no. 2, 1 January 2009 (2009-01-01), pages 105 - 110, XP008170554, ISSN: 1128-3602, Retrieved from the Internet <URL:http://www.europeanreview.org/article/604> * |
Also Published As
Publication number | Publication date |
---|---|
MA50163A (fr) | 2020-07-29 |
KR20200092939A (ko) | 2020-08-04 |
JOP20200065A1 (ar) | 2020-03-17 |
US11364282B2 (en) | 2022-06-21 |
SG11202001756YA (en) | 2020-04-29 |
US20200215165A1 (en) | 2020-07-09 |
US20220062388A1 (en) | 2022-03-03 |
CL2020000684A1 (es) | 2020-08-21 |
CA3075582A1 (en) | 2019-03-28 |
WO2019057709A1 (en) | 2019-03-28 |
EP3684372A1 (en) | 2020-07-29 |
EA202090790A1 (ru) | 2020-06-17 |
KR102468673B1 (ko) | 2022-11-17 |
MX2020002914A (es) | 2020-08-17 |
UY37885A (es) | 2018-11-30 |
BR112020005537A2 (pt) | 2020-10-06 |
AR112700A1 (es) | 2019-11-27 |
CO2020002658A2 (es) | 2020-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL264049A (en) | Compounds, preparations and methods for treating the disease | |
DK3557998T3 (da) | Sammensætninger, kompositioner og anvendelsesmetoder | |
HK1254358A1 (zh) | 用於治療突觸核蛋白病的藥劑、用途和方法 | |
IL264156A (en) | Compounds, preparations and methods for treating the disease | |
DK3510157T3 (da) | Pd-1-homing-endonucleasevarianter, sammensætninger og fremgangsmåder til anvendelse | |
DK3676297T3 (da) | Forbindelser, sammensætninger og fremgangsmåder | |
IL266596A (en) | Causes, uses and methods of treating synovialitis | |
IL253979B (en) | Methods, preparations and kits for cancer treatment | |
DK3102673T3 (da) | Fremgangsmåder og sammensætninger til behandling af beta-talassæmi | |
DK3277815T3 (da) | Oligonukleotidforbindelser til behandling af præeklampsi og andre angiogene lidelser | |
DK3177640T3 (da) | Pd-1-midler med høj affinitet og anvendelsesfremgangsmåder | |
DK3580561T3 (da) | Hla-baserede metoder, sammensætninger og anvendelse heraf | |
BR112018011709A2 (pt) | inibidores bicíclicos de pad4 | |
DK3204386T3 (da) | Substituerede aminopurinforbindelser, sammensætninger deraf og fremgangsmåder til behandling dermed | |
DK3081263T3 (da) | Sammensætninger og redskaber til behandling af glaukom | |
HK1259372A1 (zh) | 治療化合物、其組合物及使用方法 | |
EP3538189A4 (en) | COMPOSITIONS, DEVICES AND METHODS FOR TREATING OPIOID RECEPTOR-MEDIATED STATES | |
MX2018006700A (es) | Inhibidores aza-bencimidazol de peptidilarginina desiminasa (pad4). | |
DK3310190T3 (da) | Sammensætning til behandling af kød og anvendelse af denne | |
DK3200748T3 (da) | Sammensætninger og fremgangsmåder til behandling og profylakse af infektioner på operationssted | |
ZA201902781B (en) | Compositions and methods for the treatment of xerostomia | |
IL268163A (en) | Methods, compositions, and kits for treatment of cancer | |
IL271728A (en) | Materials, uses and treatment methods | |
MX2019000246A (es) | Formas en estado solido del dimesilato de palbociclib. | |
DK3662925T3 (da) | Sammensætning, der omfatter fsh, til behandling af infertilitet |